Confronto

Epitalon vs. Pasireotid

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

307297-39-8

396091-73-9

Peso molecolare

390.35 g/mol

1047.21 g/mol

Emivita

0.3 h

nessun dato

Sequenza

Ala-Glu-Asp-Gly

nessun dato

Meccanismo d'azione

Epitalon

Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Base di evidenze

Evidenza più alta

Studio sull'uomo

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Epitalon	Pasireotid
Germania	Non approvato	Su prescrizione
RU	Solo ricerca	—
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Epitalon and Pasireotid?: Epitalon is classified as "Ricerca (altro)", while Pasireotid is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Epitalon or Pasireotid?: The highest available evidence level is "Studio sull'uomo" for Epitalon and "RCT sull'uomo" for Pasireotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Epitalon and Pasireotid in Germany and the United States?: Germania: Epitalon — Non approvato, Pasireotid — Su prescrizione. Stati Uniti: Epitalon — Non approvato, Pasireotid — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Epitalon

Pasireotid

Germania

Non approvato

Su prescrizione

Solo ricerca

—

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Epitalon and Pasireotid?

Epitalon is classified as "Ricerca (altro)", while Pasireotid is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Epitalon or Pasireotid?

The highest available evidence level is "Studio sull'uomo" for Epitalon and "RCT sull'uomo" for Pasireotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Epitalon and Pasireotid in Germany and the United States?

Germania: Epitalon — Non approvato, Pasireotid — Su prescrizione. Stati Uniti: Epitalon — Non approvato, Pasireotid — Su prescrizione. These are factual summaries with source and review date on the individual pages.